l carnitine and gbb Plasma TMAO (a) (b) concentrations in placebo (grey bars) and Figure 4 from eview harmacological

doi: 10.3389/fpls.2018.00751 Received 15 February 2018 Accepted 16 May 2018 Published 07 June 2018 Volume 9 - 2018 Edited by Kendal Hirschi, Baylor College of Medicine, United States Reviewed by Toshiro Shigaki, The University of Tokyo, Japan

Steinbrecher UP

14 - 19 This however, directly holds that cytoprotective agent would be effective prophylactically (given before injury able to protect stomach mucosa) as well as therapeutically (given after injury, with the pre-existing lesion, able to rescue stomach mucosa)

Peripheral blood mononuclear cells (PBMCs) from healthy donors, obtained from peripheral blood or buffy coats, were used as control